Prof. Dr. med. Carola Berking

Lehrstuhl für Haut- und Geschlechtskrankheiten

Identifying biomarkers and novel therapeutic targets in uveal melanoma (2023) Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website-A Mixed-methods Approach (2022) Steeb T, Bruetting J, Reinhardt L, Hoffmann J, Weiler N, Heppt M, Erdmann M, et al. Journal article eImmunonkologie: Development and Launch of a Virtual Education Platform for the Immunotherapy of Cutaneous Neoplasms (2022) Kaufmann M, Steeb T, Wessely A, Meyerolbersleben M, French LEE, Berking C, Heppt M Journal article Introducing SKINFO - the new and unique web-based information platform for German-speaking skin cancer patients (2022) Steeb T, Hoffmann J, Meier F, Weber C, Bergmann M, Mueller-Schuchardt A, Weiler N, et al. Conference contribution Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry (2022) Haist M, Stege H, Lang BM, Tsochataridou A, Salzmann M, Mohr P, Schadendorf D, et al. Journal article Melanoma 2.0. Skin cancer as a paradigm for emerging diagnostic technologies, computational modelling and artificial intelligence (2022) Vera J, Lai X, Baur A, Erdmann M, Gupta S, Gutta C, Heinzerling L, et al. Journal article, Review article Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells (2022) Harrer DC, Schenkel C, Berking C, Herr W, Abken H, Dörrie J, Schaft N Journal article Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives (2022) Heppt M, Gebhardt C, Hassel JC, Alter M, Gutzmer R, Leiter U, Berking C Journal article, Review article Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages (2022) Royzman D, Peckert-Maier K, Stich L, König C, Wild A, Tauchi M, Ostalecki C, et al. Journal article Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry (2022) Mohr P, Scherrer E, Alar V, Assaf C, Beissert S, Berking C, Eigentler T, et al. Conference contribution